UA13218A - Спосіб одержаhhя заміщеhих імідазолів або їх hетоксичhих фармацевтичhо прийhятhих адитивhих солей - Google Patents

Спосіб одержаhhя заміщеhих імідазолів або їх hетоксичhих фармацевтичhо прийhятhих адитивhих солей

Info

Publication number
UA13218A
UA13218A UA4356681A UA4356681A UA13218A UA 13218 A UA13218 A UA 13218A UA 4356681 A UA4356681 A UA 4356681A UA 4356681 A UA4356681 A UA 4356681A UA 13218 A UA13218 A UA 13218A
Authority
UA
Ukraine
Prior art keywords
imidazoles
hetoxic
administrated
pharmaceutical
additive salts
Prior art date
Application number
UA4356681A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Йоханнес Кар'ялайнен Арто
Вейро Матті Кангас Лаурі
Ойва Антеро Куркела Кауко
Original Assignee
Фармос-Іхтюмя Ой
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармос-Іхтюмя Ой filed Critical Фармос-Іхтюмя Ой
Publication of UA13218A publication Critical patent/UA13218A/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
UA4356681A 1987-10-09 1988-10-07 Спосіб одержаhhя заміщеhих імідазолів або їх hетоксичhих фармацевтичhо прийhятhих адитивhих солей UA13218A (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8723715A GB2210875B (en) 1987-10-09 1987-10-09 Aromatase inhibiting 4(5)-imidazoles

Publications (1)

Publication Number Publication Date
UA13218A true UA13218A (uk) 1997-02-28

Family

ID=10625036

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4356681A UA13218A (uk) 1987-10-09 1988-10-07 Спосіб одержаhhя заміщеhих імідазолів або їх hетоксичhих фармацевтичhо прийhятhих адитивhих солей

Country Status (24)

Country Link
US (1) US5098923A (OSRAM)
EP (1) EP0311447B1 (OSRAM)
JP (1) JPH01132568A (OSRAM)
KR (1) KR890006593A (OSRAM)
CN (1) CN1036993C (OSRAM)
AU (1) AU615482B2 (OSRAM)
CA (1) CA1329616C (OSRAM)
DD (1) DD282912A5 (OSRAM)
DE (1) DE3874073T2 (OSRAM)
DK (1) DK550988A (OSRAM)
ES (1) ES2043839T3 (OSRAM)
FI (1) FI93105C (OSRAM)
GB (1) GB2210875B (OSRAM)
GR (1) GR3006343T3 (OSRAM)
HU (1) HU201024B (OSRAM)
IE (1) IE61180B1 (OSRAM)
IL (1) IL87969A (OSRAM)
LT (1) LT3658B (OSRAM)
NO (1) NO172048C (OSRAM)
NZ (1) NZ226483A (OSRAM)
PT (1) PT88717B (OSRAM)
RU (2) RU1819263C (OSRAM)
UA (1) UA13218A (OSRAM)
ZA (1) ZA887545B (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2210875B (en) 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
GB8818561D0 (en) * 1988-08-04 1988-09-07 Ici Plc Diphenylethane derivatives
GB2229719B (en) 1989-03-30 1992-04-29 Farmos Oy Novel aromatase inhibiting 4(5)-imidazoles
JPH032168A (ja) * 1989-03-30 1991-01-08 Farmos Yhtymae Oy アロマターゼ阻害活性を有する新規な４（５）―イミダゾール
GB2248058B (en) * 1990-09-21 1994-09-14 Orion Yhtymae Oy Aromatase inhibiting 4(5)-imidazoles
US5439928A (en) * 1989-03-30 1995-08-08 Orion-Yhtyma Oy Aromatase inhibiting 4(5)-imidazoles
GB9125924D0 (en) 1991-06-18 1992-02-05 Orion Yhtymae Oy Stereoisomers of an imidazole derivative
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
AU1529997A (en) * 1996-01-16 1997-08-11 Warner-Lambert Company Substituted histidine inhibitors of protein farnesyltransferase
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) * 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
HUP0002852A3 (en) * 1997-08-15 2001-11-28 Univ Durham A method of preventing or treating estrogen-dependent diseases and disorders using triphenil-ethylene derivatives
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) * 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
ES2298508T3 (es) 2002-03-26 2008-05-16 Boehringer Ingelheim Pharmaceuticals Inc. Mimeticos de glucocorticoides, metodos para prepararlos, composiciones farmaceuticas y sus usos.
WO2003082787A1 (en) * 2002-03-26 2003-10-09 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JP4373926B2 (ja) 2003-01-03 2009-11-25 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド １−プロパノール及び１−プロピルアミン誘導体ならびにグルココルチコイドリガンドとしての使用
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
ES2326907T3 (es) 2004-12-27 2009-10-21 Boehringer Ingelheim Pharmaceuticals Inc. Mimeticos de glucocorticoides, metodos para su preparacion, composiciones farmaceuticas y su uso.
EP2102170A2 (en) 2006-12-06 2009-09-23 Boehringer Ingelheim International GmbH Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
EP2095819A1 (en) * 2008-02-28 2009-09-02 Maastricht University N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
PT2300472E (pt) 2008-06-06 2012-02-20 Boehringer Ingelheim Int Miméticos de glucocorticóides, métodos de os preparar, composições farmacêuticas e suas utilizações

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4605661A (en) * 1984-06-18 1986-08-12 Eli Lilly And Company Aromastase inhibiting α,α-diarylimidazole-4(5)-propionitriles, α,α-diarylimidazole-4(5)-propionamides, and 4(5)-(2,2-diarylethyl)imidazoles
LU85747A1 (fr) * 1985-01-28 1986-08-04 Continental Pharma Derives d'imidazole leur preparation et utilisation ainsi que les compositions pharmaceutiques contenant des derives
GB2210875B (en) 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
JPH032168A (ja) 1989-03-30 1991-01-08 Farmos Yhtymae Oy アロマターゼ阻害活性を有する新規な４（５）―イミダゾール

Also Published As

Publication number Publication date
NZ226483A (en) 1991-02-26
JPH01132568A (ja) 1989-05-25
CN1033995A (zh) 1989-07-19
ES2043839T3 (es) 1994-01-01
FI93105B (fi) 1994-11-15
HUT49582A (en) 1989-10-30
DK550988A (da) 1989-04-10
US5098923A (en) 1992-03-24
CA1329616C (en) 1994-05-17
RU1819263C (ru) 1993-05-30
FI93105C (fi) 1995-02-27
NO172048C (no) 1993-06-02
DK550988D0 (da) 1988-10-03
KR890006593A (ko) 1989-06-14
DE3874073T2 (de) 1993-01-21
IE883055L (en) 1989-04-09
DE3874073D1 (de) 1992-10-01
CN1036993C (zh) 1998-01-14
GB2210875B (en) 1991-05-29
FI884497A0 (fi) 1988-09-30
GR3006343T3 (OSRAM) 1993-06-21
NO172048B (no) 1993-02-22
AU2349088A (en) 1989-04-13
PT88717B (pt) 1992-12-31
LT3658B (en) 1996-01-25
IL87969A0 (en) 1989-03-31
LTIP916A (en) 1995-03-27
NO884473D0 (no) 1988-10-07
GB2210875A (en) 1989-06-21
NO884473L (no) 1989-04-10
ZA887545B (en) 1989-06-28
IL87969A (en) 1993-04-04
DD282912A5 (de) 1990-09-26
IE61180B1 (en) 1994-10-05
AU615482B2 (en) 1991-10-03
FI884497A7 (fi) 1989-04-10
GB8723715D0 (en) 1987-11-11
EP0311447B1 (en) 1992-08-26
EP0311447A1 (en) 1989-04-12
RU2045519C1 (ru) 1995-10-10
HU201024B (en) 1990-09-28

Similar Documents

Publication Publication Date Title
UA13218A (uk) Спосіб одержаhhя заміщеhих імідазолів або їх hетоксичhих фармацевтичhо прийhятhих адитивhих солей
ES2176251T3 (es) Compuestos utilizados como inhibidores de pde iv y del factor de necrosis tumoral(tnf).
ES2054995T3 (es) Nuevos derivados del acido benzoico y acido fenilacetico, su obtencion y empleo como medicamentos.
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
TR200003879T2 (tr) İn vivo ışın tedavisine duyarlılaştırıcı özelliklere sahip farnesil protein transferaz inhibitörleri@
SU1342417A3 (ru) Cпocoб пoлучehия пpoизboдhыx 2-amиho-5-okcи-4-metилпиpиmидиha или иx kиcлotho-aддиtиbhыx coлeй
IL58775A (en) Hydroxyethyl-azole compounds,their production and pharmaceutical compositions containing them
PT934309E (pt) Novas piridil-alcano-amidas como agentes citostaticos e imunossupressivos
BE777689A (fr) Nouveaux derives de l'imidazoline, compositions therapeutiques les contenant ainsi que le procede de preparation de ces derives et de ces compositions
PT77898B (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
ZA796356B (en) New hydroxypropyl-triazole compounds, their production and their medicinal use
RU93042874A (ru) Соединения полипептидной природы, способ их получения, композиция на их основе, их применение в противоопухолевой терапии
ES8505379A1 (es) Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos
ZA806399B (en) New 2-hydroxyalkyl-3,4,5-trihydroxypiperidine compounds, their production and their medicinal use
ES8604223A1 (es) Un procedimiento para preparar derivados de purina
ATE192923T1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
FR2536075B1 (fr) Nouveaux derives de la nitrosouree, leur procede de preparation et les compositions pharmaceutiques les renfermant
IL58587A (en) Esters of 1,1,2-triphenylalkene derivatives,their preparation and pharmaceutical compositions comprising them
EP0009636A3 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivative, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds in the treatment and prophylaxis of diseases and for promoting growth of certain animals, and their manufacture
IL59295A (en) Dehydrophenylalanyl-tryptophan derivatives,their production and pharmaceutical compositions containing them
DK23887A (da) Benzimidazolderivater
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
UA19310A1 (uk) Спосіб одержаhhя заміщеhого імідазолу або його hетоксичhої фармацевтичhо прийhятhої кислотhо-адитивhої солі
BE797563A (fr) Nouveaux derives de l'acetamidine et leur procede de preparation ainsi que les compositions therapeutiques les contenant
ES8304582A1 (es) Procedimiento para preparar compuestos de estano.